oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes

oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes Comparative of to dulaglutide patients with Cardiovascular Outcomes, Safety, and Tolerability

Name: oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes Comparative of to dulaglutide patients with Cardiovascular Outcomes, Safety, and Tolerability
Brand: quatrefleurs.de
SKU: 82136668614
Price: 21.25 USD
Availability: InStock
Rating: 4.4113 (23 reviews)

SKU: 82136668614

4.4

EUR21.25 EUR67.25

Pay in 4 interest-free payments of $5.31 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

Description

O'Dwyer PJ, Hamilton TC, LaCreta FP, Gallo JM, Kilpatrick D, Halbherr T, Brennan J, Bookman MA, Hoffman J, Young RC, Comis RL, Ozols RF: Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer

doi: 10.1021/ac60333a011